Remove 2025 Remove Chronic Pain Remove State Laws Remove Treatment
article thumbnail

Article: Who is Impacted if Marijuana is Reclassified as a Schedule II Drug

Cannabis Law Report

It is also the first FDA approved drug for the treatment of patients with Dravet syndrome. For example, there is a growing body of evidence that marijuana is working for chronic pain. xxiv] If marijuana is reclassified or the pending Fairness in Federal Drug Testing Under State Laws Act (H.R. Westwood, and J.

article thumbnail

New York Medical Marijuana Guide

Cannabis Law Report

Researchers predict that the market will be valued at $7 billion by the year 2025. And according to a Nielsen analytical report , the US market of legal marijuana will reach $41 billion in revenue by 2025, meaning that New York will make up close to 17% of the market share. In 2018, the New York legal cannabis market reached $1.8

article thumbnail

Meritas Law Firms Worldwide Article: Global Cannabis Industry: The Essential Primer

Cannabis Law Report

Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. billion in 2025, according to Grandview Research. But lawyers should check their own state’s ethics opinions first.

Law 40